Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus
Clinical trial NCT02287896 · COMPLETED
Trial details
- NCT number
- NCT02287896
- Sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-09-13
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.